Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

An alleged MS-13 leader accused of working with an assassination squad that executed four people in Honduras, including the son of the country’s former president, was able to obtain a California ...